ISRG logo

Intuitive Surgical, Inc. Stock Price

NasdaqGS:ISRG Community·US$146.2b Market Cap
  • 6 Narratives written by author
  • 8 Comments on narratives written by author
  • 479 Fair Values set on narratives written by author

ISRG Share Price Performance

US$411.06
-101.12 (-19.74%)
US$565.25
Fair Value
US$411.06
-101.12 (-19.74%)
27.3% undervalued intrinsic discount
US$565.25
Fair Value
Price US$411.06
AnalystConsensusTarget US$565.25
AnalystLowTarget US$430.05
pbco US$630.48

ISRG Community Narratives

·
Fair Value US$565.25 27.3% undervalued intrinsic discount

Rising Demand And Cost Pressures Will Shape Robotic Surgery Outlook

1users have liked this narrative
1users have commented on this narrative
201users have followed this narrative
·
Fair Value US$430.05 4.4% undervalued intrinsic discount

Global Healthcare Cost Pressures And Tariffs Will Depress Margins

0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
Fair Value
·
Fair Value US$630.48 34.8% undervalued intrinsic discount

ISRG Riding the Lightning

1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
US$630.48
34.8% undervalued intrinsic discount
Fair Value
Revenue
11.47% p.a.
Profit Margin
28.38%
Future PE
62.94x
Price in 2031
US$912.04
US$532.46
22.8% undervalued intrinsic discount
Fair Value
Revenue
12% p.a.
Profit Margin
30%
Future PE
50x
Price in 2031
US$738.89
US$325.55
26.3% overvalued intrinsic discount
Fair Value
Revenue
12% p.a.
Profit Margin
25%
Future PE
45x
Price in 2030
US$451.73
US$565.25
27.3% undervalued intrinsic discount
Revenue
13.09% p.a.
Profit Margin
29.37%
Future PE
53.19x
Price in 2029
US$700.02
US$430.05
4.4% undervalued intrinsic discount
Revenue
9.49% p.a.
Profit Margin
28.68%
Future PE
45.78x
Price in 2029
US$533.97
US$750
45.2% undervalued intrinsic discount
Revenue
16.89% p.a.
Profit Margin
30.75%
Future PE
65.49x
Price in 2029
US$937.17

Trending Discussion

Updated Narratives

ISRG logo

ISRG Riding the Lightning

Fair Value: US$630.48 34.8% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ISRG logo

ISRG at FV

Fair Value: US$532.46 22.8% undervalued intrinsic discount
46 users have set this as their fair value
5 users have commented on this narrative
0 users have liked this narrative
ISRG logo

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

Fair Value: US$325.55 26.3% overvalued intrinsic discount
20 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

0 Risks
4 Rewards

Intuitive Surgical, Inc. Key Details

US$10.6b

Revenue

US$3.6b

Cost of Revenue

US$7.0b

Gross Profit

US$4.0b

Other Expenses

US$3.0b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
8.41
66.29%
28.15%
0%
View Full Analysis

About ISRG

Founded
1995
Employees
17021
CEO
David Rosa
WebsiteView website
www.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Recent ISRG News & Updates

Seeking Alpha Jun 12

Intuitive Surgical: Excellent Business, Unattractive Stock

Summary Intuitive Surgical remains a high-quality leader in robotic-assisted surgery, boasting strong recurring revenue and deep hospital integration. Despite robust earnings and procedural growth, ISRG stock has declined over 26% YTD and trades at a steep valuation premium. ISRG’s business model is sticky, with recurring sales up 84% last year and a growing installed base driving long-term revenue. Current valuation demands near-perfect execution; I prefer faster-growing alternatives like Eli Lilly and UnitedHealth at these levels. Read the full article on Seeking Alpha
Narrative Update Jun 08

ISRG: Future Returns Will Depend On Procedure Utilization Outpacing Sector Rotation Headwinds

Intuitive Surgical's updated analyst price target has moved lower in line with a reset of fair value from $611.82 to $565.25, as analysts factor in a sector wide pullback in medtech valuations, slightly softer revenue growth assumptions, modestly adjusted discount rates, and a revised future P/E of 53.19 while still citing company specific earnings leverage and product positioning in their broader rationale. Analyst Commentary Recent research on Intuitive Surgical highlights a mix of optimism on long term growth potential and caution around sector specific headwinds and valuation reset.

Recent updates

No updates